-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Day One Biopharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
- Day One Biopharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$115M, a 133% decline year-over-year.
- Day One Biopharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$293M, a 64.8% decline year-over-year.
- Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$206M, a 40.3% decline from 2022.
- Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$147M, a 102% decline from 2021.
- Day One Biopharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$72.7M, a 428% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)